Deltex Medical Group plc

DEMG.L · LSE
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Market Cap£1,713£6,855£8,275£7,370
- Cash£705£471£413£853
+ Debt£1,921£2,233£2,004£1,467
Enterprise Value£2,929£8,617£9,866£7,984
Revenue£1,776£2,482£2,259£2,398
% Growth-28.4%9.9%-5.8%
Gross Profit£1,125£1,747£1,483£1,547
% Margin63.3%70.4%65.6%64.5%
EBITDA-£1,002-£819-£748-£531
% Margin-56.4%-33%-33.1%-22.1%
Net Income-£1,282-£1,149-£967-£798
% Margin-72.2%-46.3%-42.8%-33.3%
EPS Diluted-0.001-0.002-0.002-0.002
% Growth35.3%0%-13.3%
Operating Cash Flow-£1,195-£606-£291-£68
Capital Expenditures-£370-£744-£644-£171
Free Cash Flow-£1,565-£1,350-£935-£239